COVID-19 and delivery of difficult asthma services

Nichols, Alexandra; Sonnappa-Naik, Mayank; Gardner, Laura; Richardson, Charlotte; Orr, Natalie; Jamalzadeh, Angela; Moore-Crouch, Rachel; Makhecha, Sukeshi; Wells, Charlotte; Hall, Pippa; Bush, Andrew; Fleming, Louise; Saglani, Sejal; Sonnappa, Samatha

doi:10.1136/archdischild-2021-322335

Cited by 3 publications

(3 citation statements)

References 5 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another study from the UK showed that telehealth team medicine approach in severely asthmatic children with home spirometry resulted in reduced admissions, fewer missed visits, and no increase in steroid or antibiotic prescriptions. The virtual approach was felt to be successful in maintaining asthma control 47 …”

Section: Pandemic Impact On Patient Care and Mitigation Strategiesmentioning

confidence: 99%

See 1 more Smart Citation

Allergic diseases and immunodeficiencies in children, lessons learnt from COVID‐19 pandemic by 2022: A statement from the EAACI‐section on pediatrics

Munblit

Greenhawt

Brough

et al. 2022

Pediatric Allergy Immunology

View full text Add to dashboard Cite

By the April 12, 2022, the COVID‐19 pandemic had resulted in over half a billion people being infected worldwide. There have been 6.1 million deaths directly due to the infection, but the pandemic has had many more short‐ and long‐term pervasive effects on the physical and mental health of the population. Allergic diseases are among the most prevalent noncommunicable chronic diseases in the pediatric population, and health‐care professionals and researchers were seeking answers since the beginning of pandemic. Children are at lower risk of developing severe COVID‐19 or dying from infection. Allergic diseases are not associated with a higher COVID‐19 severity and mortality, apart from severe/poorly controlled asthma. The pandemic disrupted routine health care, but many mitigation strategies, including but not limited to telemedicine, were successfully implemented to continue delivery of high‐standard care. Although children faced a multitude of pandemic‐related issues, allergic conditions were effectively treated remotely while reduction in air pollution and lack of contact with outdoor allergens resulted in improvement, particularly respiratory allergies. There is no evidence to recommend substantial changes to usual management modalities of allergic conditions in children, including allergen immunotherapy and use of biologicals. Allergic children are not at greater risk of multisystem inflammatory syndrome development, but some associations with Long COVID were reported, although the data are limited, and further research is needed. This statement of the EAACI Section on Pediatrics provides recommendations based on the lessons learnt from the pandemic, as available evidence.

show abstract

Section: Pandemic Impact On Patient Care and Mitigation Strategiesmentioning

confidence: 99%

“…The virtual approach was felt to be successful in maintaining asthma control. 47 Following the closure of allergy services in many countries, routine oral food challenges (OFC) and drug challenges were canceled. Some centers adopted strategies to mitigate delays in the service provision.…”

Section: Is It Safe To Perform Routine Clinical Procedures In Home Se...mentioning

confidence: 99%

Allergic diseases and immunodeficiencies in children, lessons learnt from COVID‐19 pandemic by 2022: A statement from the EAACI‐section on pediatrics

Munblit

Greenhawt

Brough

et al. 2022

Pediatric Allergy Immunology

View full text Add to dashboard Cite

show abstract

“…Opportunities for home-based spirometry measurement also increased during the pandemic, particularly when pulmonary function laboratories closed or reduced their volumes to decrease the spread of COVID-19 that may be attributed to the aerosol-generating procedure. Prior to the pandemic, studies evaluated the utility of home spirometry to monitor children with asthma and showed its potential for use [ 28 ]. Nichols and colleagues provided home spirometers to children with asthma and asked them to perform spirometry 24 h prior to their in-person or virtual visit or if symptomatic from asthma.…”

Section: Opportunities From the Covid-19 Pandemic That Can Impact Lon...mentioning

confidence: 99%

Applying Lessons from the COVID-19 Pandemic to Improve Pediatric Asthma Care

Lovinsky‐Desir

Volerman

2022

Pulm Ther

View full text Add to dashboard Cite

Asthma is the most common chronic childhood condition and is a risk factor for severe respiratory viral infections. Thus, early during the coronavirus disease 2019 (COVID-19) pandemic there was concern that children with asthma would be at risk for severe COVID-19 illness and that asthma control could worsen as a result of the pandemic. This article seeks to summarize what was learned in the early stages of the pandemic about the impact of COVID-19 on children with asthma. We review evidence from several studies that demonstrated a significant decline in asthma morbidity in the first year of the pandemic. Additionally, we describe several potential mechanisms that may explain the reduced frequency in childhood asthma exacerbations as well as review lessons learned for future management of childhood asthma. While the COVID-19 pandemic initially brought uncertainty, it soon became clear that the pandemic had several positive effects for children with asthma. Now we can apply the lessons that were learned during the pandemic to re-examine asthma care practices as well as advocate for best approaches for asthma management.

show abstract